Dietary Supplement
Caseinate
Caseinate is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Absorption of Peptides, Fluid, and Electrolytes in Patients With an Ileostomy
NCT04141826
completedphase_2
Study to Compare Milk Protein Isolate (MPI) With Caseinate in Terms of Protein Utilization
NCT01599988
completednot_applicable
Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD
NCT01418469
Clinical Trials (3)
Showing 3 of 3 trials
NCT04141826Not Applicable
Absorption of Peptides, Fluid, and Electrolytes in Patients With an Ileostomy
NCT01599988Phase 2
Study to Compare Milk Protein Isolate (MPI) With Caseinate in Terms of Protein Utilization
NCT01418469Not Applicable
Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3